NewHold Investment Corp IV NHIV FINANCIAL
Company Overview
NewHold Investment Corp IV focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in New York, New York.
Growth & Price Performance
Stock Price Performance
| 1 Year: | +0.50% |
| 6 Months: | - |
| 3 Months: | - |
| 1 Month: | -0.59% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- RSI (14)40.75 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Financial Services).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | NHIV NewHold Investment Corp IV FINANCIAL | 10.10 | - | $209.74M | 0.00% | - | - | - | - |
| 2 | JPM JPMorgan Chase & Co. SPXR3KFINANCIAL | 353.51 | 15.15 | $939.70B | 1.72% | - | 17.79% | 12.50% | 14.83% |
| 3 | BRK-B Berkshire Hathaway Inc. SPXFINANCIAL | 505.83 | 12.72 | $712.23B | 0.00% | - | 12.12% | 4.18% | 9.44% |
| 4 | V Visa Inc. SPXR3KFINANCIAL | 368.64 | 31.35 | $628.20B | 0.72% | 37.15% | 61.19% | 14.33% | 13.04% |
| 5 | MA Mastercard Incorporated SPXR3KFINANCIAL | 570.89 | 31.44 | $496.37B | 0.62% | 60.19% | - | 12.29% | 19.21% |
| 6 | BAC Bank of America Corporation SPXR3KFINANCIAL | 62.39 | 14.41 | $436.28B | 2.04% | - | 11.20% | 3.14% | 4.27% |
| 7 | BRK-A Berkshire Hathaway Inc. FINANCIAL | 757,791.00 | 12.71 | $370.14B | 0.00% | - | 12.12% | 7.60% | 10.02% |
| 8 | HSBC HSBC Holdings plc FINANCIAL | 106.26 | 15.18 | $363.70B | 3.65% | - | 13.10% | 9.75% | 12.72% |
| 9 | MS Morgan Stanley SPXR3KFINANCIAL | 216.24 | 17.48 | $339.62B | 2.26% | - | 17.97% | 3.76% | 9.66% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Cost of Revenue | - | - | - |
| Gross Profit | - | - | - |
| Operating Expenses | 47.00K | 38.00K | 619.00K |
| Operating Income | -47.00K | -38.00K | -619.00K |
| EBITDA | -47.00K | -38.00K | -619.00K |
| Interest Expense | - | - | - |
| Pretax Income | -47.00K | -38.00K | 854.00K |
| Tax Provision | - | - | - |
| Net Income | -47.00K | -38.00K | 854.00K |
| Diluted EPS | -0.00 | -0.00 | 0.04 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2025 |
|---|---|
| Total Assets | 91.00K |
| Current Assets | 8.00K |
| Cash & Equivalents | - |
| Inventory | - |
| Receivables | - |
| Total Liabilities | 113.00K |
| Current Liabilities | 113.00K |
| Long Term Debt | - |
| Total Debt | - |
| Total Equity | -22.00K |
| Shares Outstanding | 24.80M |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Adage Capital Partners GP L.L.C. | 7.58% | 1.57M | $15.83M |
| 2 | Alberta Investment Management Corp | 4.82% | 1.00M | $10.05M |
| 3 | Linden Advisors LP | 4.57% | 950.00K | $9.55M |
| 4 | Healthcare of Ontario Pension Plan Trust Fund | 4.09% | 850.00K | $8.54M |
| 5 | Moore Capital Management, LP | 3.37% | 700.00K | $7.04M |
| 6 | Wealthspring Capital LLC | 2.77% | 575.05K | $5.78M |
| 7 | Millennium Management Llc | 2.77% | 575.00K | $5.78M |
| 8 | Commonwealth Of Pennsylvania Public School Empls Retrmt Sys | 2.53% | 525.00K | $5.28M |
| 9 | Mint Tower Capital Management B.V. | 2.17% | 450.00K | $4.52M |
| 10 | Magnetar Financial LLC | 2.00% | 416.35K | $4.18M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NHIV
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE9vMUFXbXB3Y1poeXM2NFV0VzN3WWdDSlVDNy1LdHozWGlub0xJN1ZMNnFROWF4b3pFbV9za2VoWTRLaHp3V2IzY2g2TDJJUERV?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
Many Investors Are Still Treating Gilead Sciences Like a Has-Been HIV Stock. 4 Drug Launches This Year Could Prove Them Wrong. - The Motley Fool
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxPemtSazhHR2l3cm10cXdob29saU5wZFBkT1F4VTBnRktJNElkUE05a2FvNlNweC1KQjdJQVFwMVB2MDVvS3JYRmd1TjR4dWlCblBUZkZGYWdiQ0lWaTVYUElrcjZVTXJxZVBPclIzYjlhMkFuc2w1ekRQTDlJX3hEUEg4RjZwSmdiNl9QVD…
Aging with HIV: What the Next Major Challenge Is for Drug Development - Infection Control Today
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxQSWEtNjk0U3lrMnBSVTF0MEtWSjVvRElEWjNEZWRybm8wMWZRU0Rna0tXazVjWmRmbjlpZllFYlJZN2xfbkdnN3V5c21ZbnFlMkhEbDRLa0R6YzB2eFlyMm14MXVwak9mdENNcVNJd3R0WG4yLUVibUxBX3R0YmptMzlCNEtqSG1sT21hMU…
NewHold Investment Corp IV (NHIV) 10K Form and Latest SEC Filings 2026 - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE50LWRNVVRkOFVOYjFwN1JETmlWZEZLMEVsYUswSlplVUpLbHhfOVdBTW04SVBiei1PcGRWTERIeTNFTXVMMWxBdkEzMEh3aXJfamExV0R1Y2VmSkFIVEtKT092V3pEQ0s3UFE?oc=5" target="_blank">NewHold Investment Corp …
UVA Health Effort Aims To Improve HIV Care Across America - UVA Today
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQR1VZWDVXTEJMOXZvaVRIUi05eVcyVDViNjZYVmVwRldMazdibHFRQjRtOGlpeGVHWV8wbEVHSXRWM0dlZEotcDhTeUxwVWNDeGxWdG84cm9xRFlPbS0tSWxsTVQzdDBlMWhKeVk4QUI2U2FPa2RKV0VaT0sxaUN6STdrN3BsSUIwM19Raj…
Why Gilead Stock Surged 8%, Flirting With A Breakout - Investor's Business Daily
<a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxOVlpzR3JKSVJnYzlXMDJvRVdKNHRiMHJIMDQ4UVlRU1RvQklzMFE4VlVGX0M1ZGp2VGlwQUFCd0ItaUNyVW5DdjFmTnVEa2NkTmdPMmgwamxFYmpkTVdRX0k5RzNucmM5alFoT0RGdkJJSXFid3FQZFpROTVhd2dvdWJIVGdsQQ?oc=5" t…
NHIV — Frequently Asked Questions
What is the current share price of NewHold Investment Corp IV (NHIV)?
As of 2026-09-19 21:16 PDT, NewHold Investment Corp IV (NHIV) trades at $10.10 on NasdaqGM. Its 52-week range is $9.95 to $10.16.
What is the market capitalisation of NHIV?
NewHold Investment Corp IV (NHIV) has a market capitalisation of $209.74M on NasdaqGM.
Is NHIV a good stock to buy?
This page provides a data-driven analysis of NewHold Investment Corp IV (NHIV), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.